Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:49 PM UTC
| NCT Number | NCT06570798 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE2 |
| Target Enrollment | 220 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | May 7, 2026 (May 7, 2026) |
As of July 17, 2026: Clinical trial NCT06570798 is currently recruiting participants. This phase2 study for systemic lupus erythematosus is actively seeking new participants at 17 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06570798 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06570798 was last updated May 7, 2026 (May 7, 2026). HelloStudys verifies this status automatically.